Check out our latest blog by Dr. Suvekshya Aryal, Research Scientist at VivoSense! Discover how we enhance patient-centricity in digital health by navigating regulatory guidance and implementing best practices. Explore solutions that put patients first, ensuring compliance and innovation work together. Read more on our website and join the discussion on developing healthcare! Read the full article here: https://hubs.ly/Q02G0TG-0 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers
VivoSense, Inc.
Biotechnology Research
Newport Coast, CA 3,943 followers
Advancing clinical trials research and healthcare delivery with analytics & AI for all wearable sensor data, ePRO/eCOA
About us
VivoSense is the world leader in data analysis consulting and software, specializing in wearable sensor physiological monitoring solutions for clinical trials, healthcare research, and consumer wellness. VivoSense develops regulatory compliant digital biomarkers using the data from wearable sensors. Digital biomarkers are used to accurately measure drug and treatment effects in patients in regulated clinical trials and healthcare research. VivoSense is the first analytics company to develop novel digital biomarkers from wearable sensor data, which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials. Several of these studies are in rare disease indication and have reached the open-label phase of development at top-ten pharma.
- Website
-
https://www.vivosense.com/
External link for VivoSense, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Newport Coast, CA
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Physiological monitoring, Physiological algorithm development, Physiological hardware and software integration, Physiological software solutions, Wearable sensors, Clinical Trials, data analysis, Cloud platform, Digital biomarker development , Clinical outcome measures, ePRO, Data visualization, Regulatory compliance , FDA, Heart Rate Variability , Respiratory monitoring , AI, Machine Learning , Deep learning, and Real world evidence (RWE)
Locations
-
Primary
27 Dorian
Newport Coast, CA 92657-1104, US
Employees at VivoSense, Inc.
Updates
-
VivoSense offers an in-depth analysis of implementing patient-centric solutions in digital evidence generation. The discussion covers innovative strategies prioritizing patient needs, significantly enhancing the quality and relevance of clinical data. By focusing on patient-centric approaches, Vivosense aims to transform the future of digital health. Discover more insights here: https://hubs.la/Q02DMKm60 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers
Implementing Patient-Centric Solutions in Digital Evidence Generation - Vivosense
vivosense.com
-
Millions of people are affected by neurodegenerative diseases, which pose significant challenges for diagnosis and treatment due to the invasive nature of traditional monitoring methods. Learn how wearable sensors are transforming the diagnosis and treatment of neurodegenerative diseases by capturing real-world data on patient symptoms and physiological outcomes. Read more here: https://hubs.la/Q02DMMfN0 #neurodegenerativedisease #wearablesensors #digitalhealth #patientcare #innovation
Understanding Neurodegenerative Diseases with Wearable Sensors - Vivosense
vivosense.com
-
Discover how VivoSense uses BioRadio's RIP technology to advance Rett Syndrome research. Their precise respiratory measurements in a multi-center clinical trial provide crucial insights for better patient outcomes. Learn more about their groundbreaking work here: https://hubs.la/Q02DMKSS0 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers
Case Study: RETT Syndrome - Vivosense
vivosense.com
-
In today's digital landscape, patient-centric solutions are revolutionizing evidence generation. Our blog explores how integrating these innovative approaches can enhance research outcomes and patient engagement. Uncover critical strategies for successful implementation and understand their profound impact on the future of digital medicine. Explore the details here: https://hubs.la/Q02DMHfj0 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers
Digital Biomarkers: Pandemic Impact, Barriers, Trends, Hype, and Hope - Vivosense
vivosense.com
-
Kate Lyden, Chief Science Officer at VivoSense, discusses the limitations and future of digital biomarkers. Current barriers include the need for more validity evidence. The future holds promise for patient-centric approaches and precision medicine through continuous, real-world data capture from wearables and other sources. Integrating and interpreting these data is key to their success. Learn more on https://hubs.la/Q02yVlqZ0 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers
Digital Biomarkers: Current Limitations and Future Outlook - Vivosense
vivosense.com
-
Don't miss Senior Research Scientist Shelby Bachman, PhD's session on 'Digital Measures of Physical Function in Oncology' with the Sony mHealth Watch! Join us tomorrow, June 26, 2024, at Roche Headquarters in Basel, Switzerland, for the 7th Annual Digital Biomarkers in Clinical Trials Summit. This global forum brings together experts from pharma, clinical trials, technology, and digital health to explore innovative ways of leveraging digital biomarkers as endpoints in drug development. Register now: https://hubs.la/Q02BbnqL0 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers"
Join Senior Research Scientist Shelby Bachman, PhD for Roche Digital Biomarkers in Clinical Trials Summit
digitalbiomarkers.panagorapharma.com
-
Join us for an insightful session with Dr. Jen Blankenship, Senior Research Scientist, as she presents innovative developments in patient-centric digital sleep assessment tools. This webinar will focus on innovative solutions for individuals experiencing short and disrupted sleep patterns. 📅 Date: July 26, 2024 🕒 Time: 11am – 3pm ET Gain valuable insights from a leading expert and enhance your understanding of the latest advancements in sleep health technology. View more upcoming events here: https://hubs.la/Q02D0xy00
-
-
Join us at the upcoming Joint FDA/FNIH Workshop on Digital Measures! Our Lead Research Scientist, Krista Leonard-Corzo, PhD., will be sharing her expertise on navigating the complexities of developing derived endpoints. This workshop is a fantastic opportunity to explore cutting-edge methodologies and regulatory perspectives that shape the future of digital health. Don't miss out on this insightful session! Date: June 24-25, 2024 Learn more and register: https://hubs.la/Q02Cxb7P0 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers
Join Lead Research Scientist, Krista Leonard-Corzo, PhD for Joint FDA/FNIH Workshop on Digital Measures
https://fnih.org
-
In a Pharmaphorum interview, VivoSense's Co-Founder & Chief Product Officer Dudley Tabakin and new board members discuss how their $25M Series A funding will boost wearable sensor data use in clinical trials. They highlight VivoSense’s software's capability to process diverse wearable data, enhancing patient monitoring and clinical trial outcomes. Discover more insights on https://hubs.la/Q02yVkjq0 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers
Pharmaphorum Interview: Accelerating Wearables in Clinical Trials - Vivosense
vivosense.com